Additional file 4: Table S3. of Development of a 4-aminopyrazolo[3,4-d]pyrimidine-based dual IGF1R/Src inhibitor as a novel anticancer agent with minimal toxicity

Lee, Ho; Pham, Phuong; Hyun, Seung; Baek, Byungyeob; Kim, Byungjin; Kim, Yunha; Min, Hye-Young; Lee, Jeeyeon; Lee, Ho-Young

doi:10.6084/m9.figshare.5900686.v1

12943_2018_802_MOESM4_ESM.pdf (176.62 kB)

Additional file 4: Table S3. of Development of a 4-aminopyrazolo[3,4-d]pyrimidine-based dual IGF1R/Src inhibitor as a novel anticancer agent with minimal toxicity

journal contribution

posted on 2018-02-19, 05:00 authored by Ho Lee, Phuong Pham, Seung Hyun, Byungyeob Baek, Byungjin Kim, Yunha Kim, Hye-Young Min, Jeeyeon Lee, Ho-Young Lee

The IC50 values showing the inhibitory effect of LL28 on the anchorage-dependent colony -forming ability of a panel of human lung cancer cells. (PDF 176Â kb)

Funding

Ministry of Science ICT and Future Planning

History

Usage metrics

Keywords

Additional LL 28 panel anchorage-dependent colony novel anticancer agent IGF 1R inhibitor 4-IC 50 values PDF 176Â kb ability lung cancer cells aminopyrazolo 3.toxicity

Licence

CC BY + CC0

Exports

RefWorks

BibTeX

Ref. manager

Endnote

DataCite

NLM

DC

Additional file 4: Table S3. of Development of a 4-aminopyrazolo[3,4-d]pyrimidine-based dual IGF1R/Src inhibitor as a novel anticancer agent with minimal toxicity

Funding

Ministry of Science ICT and Future Planning

History

Usage metrics

Categories

Keywords

Licence

Exports